Paige raises $15M more for AI, cancer pathology

2020 02 20 18 12 3118 Money Bills 400

Artificial intelligence (AI) pathology company Paige has raised $15 million in additional funding from Goldman Sachs to support its efforts related to cancer diagnostics and remote reading for pathologists.

The $15 million investment comes on the heels of a previously undisclosed investment by Goldman Sachs in April. Paige revealed this first investment was worth $5 million.

The new funding from Goldman Sachs and Healthcare Venture Partners brings Paige's series B funding total to $70 million. Paige has now raised more than $95 million in total capital, the company noted.

Page 1 of 4
Next Page